MannKind reported 37.4 in PE Price to Earnings for its fiscal quarter ending in June of 2025.


Pe Change Date
Adma Biologics 21.68 1.37 Jun/2025
Dynavax Technologies 47.66 38.52 Jun/2025
Eli Lilly 37 7.55 Jun/2025
Halozyme Therapeutics 11.9 5.04 Jun/2025
MannKind 37.4 12.9 Jun/2025
Merck 8.58 4.74 Jun/2025
Novo Nordisk 21.15 18.44 Mar/2025
Pfizer 9.12 8.86 Jun/2025
Sanofi 16.47 6.85 Jun/2025
Xencor 29.92 3.22 Sep/2022